Antifungal Drugs & Fungi B- Exam IV Flashcards
Why are there fewer effective antifungal agents?
because of the similarity of human cells and fungal cells
It is easier to treat ___ fungal infections than ____ fungal infections
superficial mycoses; systemic infections
Sterol found in fungal cell membranes; human cells have cholesterol instead of tis:
ergosterol
Where is ergosterol found?
in fungal cell membranes
Antifungal treatment that binds ergosterol in fungal membranes:
polyene compounds
Give an example of a polyene compound that is used to treat systemic disease:
amphotericin B
Given an example of a polyene compound that is used to treat topical disease:
nystatin
Polyene compounds cause ___, leading to:
altered membrane permeability; leakage of cell constituents & cell death
Polyenes bind ____ in mammalian cells but this is less strongly than they bind ___
cholesterol; ergosterol
What is the basis for drug toxicity with the polyene compounds?
their ability to bind cholesterol in mammalian cells
Why is fillipin a potent but toxic anti-fungal agent?
due to the binding of cholesterol
Terbinafine (TBF) acts on the Ergosterol biosynthetic pathway at the ____ step.
squalene epoxidase
Itraconazole (ITZ) acts on the Ergosterol biosynthetic pathway at the ____ step.
C-14 demethylase
Function to block ergosterol synthesis by inhibiting squalene epoxidase activity:
Allylamines
Give an example of an Allylamine that functions to block ergosterol synthesis:
Terbinafine (TBF)
Allylamines are mainly effective on the:
dermatophytes
What form of allylamines are most effective on dermatophytes?
topical or tablet formulations
Function to block ergosterol synthesis by inhibiting cytochrome P450-dependent 14(alpha)-lanosterol demtheylation:
azoles
What was the first oral azole?
Ketoconazole
What are some downfalls to ketoconazole? (the first oral azole)
significant numbers of side effects and drug interactions
What was created to supersede/replace ketoconazole?
Itraconazole
Itraconazole is preferred over ketoconazole because:
active against many fungi and has improved safety profile
What fungal species is itraconazole effective against?
- candida species
- cryptococcus
- aspergillus
- endemic (systemic) fungi
- dermaphytes
antifungal agent that inhibits the synthesis of beta-(1,3)-D-glucan, an essential component of fungal cells walls
Echinochandins
What is the significant of Echinocandins inhibiting the synthesis of beta-(1,3)-D-glucan:
This is an essential component of fungal cell walls
Echinocandins are ___ compared to agents that target cell membrane components
more selective
Echinocandins can be considered ___ against aspergillus and candida species
narrow spectrum
Why are echinocandins considered “narrow spectrum” against aspergillus and candida species?
because these fungi have larger amounts of beta-(1,3)-D-glucans
A type of echinocandin that is administered intravenously and has minimal toxicity:
Caspofungin
Antifungal drug mechanism that interferes with fungal protein and DNA synthesis:
Pyrimidine inhibition
Pyrimidine inhibition interferes with:
fungal protein and DNA synthesis
antifungal drug mechanism “pyrimidine inhibition” is active against what species?
candida species and cryptococcus neoformans
Why must drugs using the mechanism “pyrimidine inhibition” be used in combination with another antifungal drug?
because resistance develops quickly if used alone
High risk categories for opportunistic mycoses:
- immunocompromised individuals
- burn victims
- long-term IV catheter users
- broad-spectrum antibiotic therapy
- DM
Candidiasis is caused by the fungal species: (3)
- candida albicans
- candida glabrata
- candida parapsilosis
Predominant species of candida colonizing humans and responsible for most candidiasis infections:
candida albicans
responsible for some candidiasis infections and often resistant to some anti-fungals:
candida glabrata
responsible for some candidiasis infections and common cause of catheter-related infections:
candida parapsilosis
What are two categories of diseases caused by candidiasis?
local disease vs. systemic invasive disease